SE8008189L - Foreningar med antiallergisk och antiulceros verkan, nemligen 1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxamider och mellanprodukter for dessa - Google Patents

Foreningar med antiallergisk och antiulceros verkan, nemligen 1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxamider och mellanprodukter for dessa

Info

Publication number
SE8008189L
SE8008189L SE8008189A SE8008189A SE8008189L SE 8008189 L SE8008189 L SE 8008189L SE 8008189 A SE8008189 A SE 8008189A SE 8008189 A SE8008189 A SE 8008189A SE 8008189 L SE8008189 L SE 8008189L
Authority
SE
Sweden
Prior art keywords
formula
intermediates
compounds
carbon atoms
antiulceros
Prior art date
Application number
SE8008189A
Other languages
English (en)
Other versions
SE448732B (sv
Inventor
S B Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE8008189L publication Critical patent/SE8008189L/sv
Publication of SE448732B publication Critical patent/SE448732B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
SE8008189A 1979-11-23 1980-11-21 N-(5-tetrazolyl)-1-oxo-1h-tiazolo /3,2-a/-pyrimidin-2-karboxamider med antiallergisk och antiulceros verkan samt motsvarande 2-karboxylsyror SE448732B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9663179A 1979-11-23 1979-11-23

Publications (2)

Publication Number Publication Date
SE8008189L true SE8008189L (sv) 1981-05-24
SE448732B SE448732B (sv) 1987-03-16

Family

ID=22258306

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8008189A SE448732B (sv) 1979-11-23 1980-11-21 N-(5-tetrazolyl)-1-oxo-1h-tiazolo /3,2-a/-pyrimidin-2-karboxamider med antiallergisk och antiulceros verkan samt motsvarande 2-karboxylsyror

Country Status (35)

Country Link
JP (1) JPS5687586A (sv)
KR (1) KR830004322A (sv)
AR (2) AR228859A1 (sv)
AT (1) AT380883B (sv)
AU (1) AU520995B2 (sv)
BE (1) BE886319A (sv)
CA (1) CA1143731A (sv)
CH (1) CH649299A5 (sv)
CS (1) CS241476B2 (sv)
DD (1) DD154608A5 (sv)
DE (2) DE3050491C2 (sv)
DK (1) DK151811C (sv)
EG (1) EG14929A (sv)
ES (1) ES497066A0 (sv)
FI (1) FI67706C (sv)
FR (1) FR2470132A1 (sv)
GB (1) GB2063862B (sv)
GR (1) GR72132B (sv)
GT (1) GT198066458A (sv)
HU (1) HU179091B (sv)
IE (1) IE50404B1 (sv)
IL (1) IL61535A (sv)
IN (1) IN154926B (sv)
IT (1) IT1209373B (sv)
LU (1) LU82950A1 (sv)
NL (1) NL182565C (sv)
NO (1) NO803521L (sv)
NZ (1) NZ195596A (sv)
PH (1) PH16666A (sv)
PL (1) PL132354B1 (sv)
PT (1) PT72090B (sv)
SE (1) SE448732B (sv)
SU (1) SU1042620A3 (sv)
YU (1) YU41953B (sv)
ZA (1) ZA807293B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
JP2690742B2 (ja) * 1987-03-30 1997-12-17 第一製薬株式会社 複素環アミン誘導体
NZ228447A (en) * 1988-03-28 1990-08-28 Janssen Pharmaceutica Nv Cosmetic or pharmaceutical composition possessing serotonin antogonistic activity
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1331059A (en) * 1971-04-19 1973-09-19 Lilly Industries Ltd Pyrimidotriazinone compounds
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
DE2810863A1 (de) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones

Also Published As

Publication number Publication date
ES8203363A1 (es) 1982-04-01
NZ195596A (en) 1984-05-31
PH16666A (en) 1983-12-13
FR2470132A1 (fr) 1981-05-29
DE3043979C2 (de) 1986-08-21
NO803521L (no) 1981-05-25
IT8026176A0 (it) 1980-11-21
CS241476B2 (en) 1986-03-13
PL132354B1 (en) 1985-02-28
SU1042620A3 (ru) 1983-09-15
YU41953B (en) 1988-02-29
CS782080A2 (en) 1985-06-13
CA1143731A (en) 1983-03-29
LU82950A1 (fr) 1981-06-04
KR830004322A (ko) 1983-07-09
YU295080A (en) 1983-06-30
AU6459580A (en) 1981-05-28
GB2063862A (en) 1981-06-10
ES497066A0 (es) 1982-04-01
JPS617432B2 (sv) 1986-03-06
GB2063862B (en) 1983-06-22
DE3043979A1 (de) 1981-09-03
AU520995B2 (en) 1982-03-11
FI67706C (fi) 1985-05-10
HU179091B (en) 1982-08-28
DE3050491C2 (de) 1985-10-10
AR228859A1 (es) 1983-04-29
IE50404B1 (en) 1986-04-16
AR231296A1 (es) 1984-10-31
DD154608A5 (de) 1982-04-07
DK413180A (da) 1981-05-24
JPS5687586A (en) 1981-07-16
CH649299A5 (fr) 1985-05-15
ZA807293B (en) 1981-12-30
NL182565C (nl) 1988-04-05
BE886319A (fr) 1981-05-25
EG14929A (en) 1989-01-30
PT72090B (en) 1981-09-29
SE448732B (sv) 1987-03-16
IL61535A0 (en) 1980-12-31
DK151811B (da) 1988-01-04
GR72132B (sv) 1983-09-19
IL61535A (en) 1984-06-29
NL8006362A (nl) 1981-06-16
IE802418L (en) 1981-05-23
GT198066458A (es) 1982-05-15
FI67706B (fi) 1985-01-31
IT1209373B (it) 1989-07-16
FR2470132B1 (sv) 1983-07-29
ATA570780A (de) 1985-12-15
DK151811C (da) 1988-06-06
PL228008A1 (sv) 1981-12-11
PT72090A (en) 1980-12-01
NL182565B (nl) 1987-11-02
AT380883B (de) 1986-07-25
IN154926B (sv) 1984-12-22
FI803628L (fi) 1981-05-24

Similar Documents

Publication Publication Date Title
ATE45579T1 (de) Diazabicyclo-(3,3,1)-nonane.
DE68901153D1 (de) Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
FI810250L (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva heterocykliska foereningar
FI803277L (fi) Morfolinderivat
FI851261L (fi) Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
SE8008189L (sv) Foreningar med antiallergisk och antiulceros verkan, nemligen 1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxamider och mellanprodukter for dessa
DK288686A (da) Farmaceutiske praeparater
NO158256C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trisubstituerte pyrimido(5,4-d)pyrimidiner.
AU554959B2 (en) Triazolo(4,3-a) quinazolin-5-ones
NO153138C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidobenzoazepinderivater.
PT89082A (pt) Processo para a preparacao de novos derivados n-(23-vinblastinoilicos)do acido 1-amino-metilfosfonico
ES543301A0 (es) Cefalosporinas
ES2117003T3 (es) Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen.
FI803654L (fi) Nya substituerade 2-fenylaminoimidazoliner-(2) deras syraadditionssalter dessa foereningar innehaollande laekemedel och deras framstaellningsfoerfarande
ES2135384T3 (es) Derivados de 1,4-dihidropiridina opticamente activos y procedimientos para producirlos.
DK280883A (da) Organophosphat-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse som midler til bekaempelse af skadelige organismer
YU106191A (sh) Aminobenzodiazepini
SE8303718L (sv) E-homo-enurnanderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa foreningar

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8008189-6

Effective date: 19900706

Format of ref document f/p: F